References of "Petrossians, Patrick"
     in
Bookmark and Share    
Full Text
See detailLessons from the Liege Acromegaly Survey (LAS)
PETROSSIANS, Patrick ULiege; Zacharieva, Sabina; Chanson, Philippe et al

in Endocrine Abstracts - 15 the European Congress of Endocrinology (2013, May)

Detailed reference viewed: 44 (5 ULiège)
Full Text
See detailThe clinical and genetic characteristics of patients with gigantism
Rostomyan, Liliya ULiege; Daly, Adrian ULiege; Tichomirowa, M et al

in Symposium "Perspectives in Endocrinology" - Congresses Highlights 2012: ECE Firenze, ENDO Houston, ESPE Leipzig, SFE Toulouse, IWMEN Liège (2013)

Detailed reference viewed: 57 (6 ULiège)
Full Text
Peer Reviewed
See detailMalabsorption des hormones thyroïdiennes... ou simple manque de compliance ?
Benoit, Arnaud ULiege; BOUQUEGNEAU, Antoine ULiege; PETROSSIANS, Patrick ULiege et al

in Revue Médicale de Liège (2013), 68(3), 118-121

Detailed reference viewed: 176 (7 ULiège)
Full Text
See detailThe clinical and genetic characteristics of patients with gigantism
Rostomyan, Liliya ULiege; Daly, Adrian ULiege; Tichomirova, M et al

in Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia (2012, September)

Detailed reference viewed: 33 (2 ULiège)
Full Text
See detailErythropoiesis in acromegaly : effect of GH or IGF-1 ? Data from the LAS (Liege Acromegaly Survey)
PETROSSIANS, Patrick ULiege; Zacharieva, S; Chanson, P et al

in Journal für Klinische Endokrinologie und Stoffwechsel (2012, September), 5(3), 45

Detailed reference viewed: 28 (4 ULiège)
Full Text
See detailGH or IGF-1 : which one is raising blood glucose ? Hints from the LAS (Liege Acromegaly Survey)
PETROSSIANS, Patrick ULiege; Zacharieva, S; Chanson, P et al

in Journal of Klinische Endokrinologie und Stoffwechsel (2012, September), 5(3),

Detailed reference viewed: 23 (2 ULiège)
Full Text
See detailAge, GH and tumor size : the triangular relation in acromegaly. Data from the LAS (Liege Acromegaly Survey)
PETROSSIANS, Patrick ULiege; Zacharieva, S; Chanson, P et al

in Journal für Klinische Endokrinologie und Stoffwechsel (2012, September), 5(3), 43

Detailed reference viewed: 42 (7 ULiège)
Full Text
See detailAging of the newly diagnosed acromegalic patients : data frome the LAS (Liege Acromegaly Survey)
PETROSSIANS, Patrick ULiege; Zacharieva, S; Chanson, P et al

in Journal für Klinische Endokrinologie und Stoffwechsel (2012, September), 5(3), 33

Detailed reference viewed: 25 (3 ULiège)
Full Text
See detailCaracteristicas de prolactinomas resisitentes a dosis estandar de cabergolina : un estudio multicentrico en 92 pacientes
Beckers, Albert ULiege; Jaffrain-Réa, ML; VROONEN, Laurent ULiege et al

in Abstract book - 54 Congreso Sociedad Espanola de Endocrinologia y nutrition (2012, May 23)

Detailed reference viewed: 39 (0 ULiège)
Full Text
See detailEl sindrome tiro-gastrico : screening en 410 pacientes atendidos pro patologia tiroidea
Tome, M; VALDES SOCIN, Hernan Gonzalo ULiege; Auriemma, R et al

in Abstract book - 54 Congreso Sociedad Espanola de Endocrinologia y nutrition (2012, May 23)

Detailed reference viewed: 44 (1 ULiège)
Full Text
Peer Reviewed
See detailClinical characterization of cabergoline resistant prolactinomas : a multicenter experience on 92 patients
VROONEN, Laurent ULiege; Jaffrain Rea, ML; PETROSSIANS, Patrick ULiege et al

in Annales d'Endocrinologie (2012, April), 73(2), 153

Detailed reference viewed: 43 (5 ULiège)
Full Text
See detailThe clinical and genetic characteristics of patients with gigantism
Rostomyan, Liliya ULiege; Daly, Adrian ULiege; Tichomirowa, M et al

in Abstract book - Aspiring excellence : Pituitary expert forum (2012)

Detailed reference viewed: 22 (2 ULiège)
Full Text
Peer Reviewed
See detailThe Liege Acromegaly Survey (LAS) : A new software tool for the study of acromegaly
PETROSSIANS, Patrick ULiege; Tichomirowa, M; Stevenaert, Achille ULiege et al

in Annales d'Endocrinologie (2012), 73

Detailed reference viewed: 68 (14 ULiège)
Full Text
Peer Reviewed
See detailProlactinomas Resistant to Standard Doses of Cabergoline : A multicenter study of 92 patients
VROONEN, Laurent ULiege; Jaffrain-Rea, ML; PETROSSIANS, Patrick ULiege et al

in European Journal of Endocrinology (2012), 167

Detailed reference viewed: 58 (11 ULiège)
Full Text
See detailClinical characterization of cabergoline resistant prolactinomas : a multicenter experience on 92 patients
VROONEN, Laurent ULiege; Jaffrain-Rea, M. L.; PETROSSIANS, Patrick ULiege et al

in ENEA Munich - abstract book (2011, December)

Detailed reference viewed: 34 (4 ULiège)
See detailLong-term outcome and complication rates in patients with macroprolactinomas treated with different therapeutic approaches : a comparative study of 184 patients
Elenkova, A.; PETROSSIANS, Patrick ULiege; Vasilev, V. et al

in ENEA Munich - abstract book (2011, December)

Detailed reference viewed: 19 (1 ULiège)
Full Text
See detailDrospirenone and interference with renin-antiotensin system
VROONEN, Laurent ULiege; Cavalier, Etienne ULiege; Vranken, Laura ULiege et al

in Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie (2011)

Detailed reference viewed: 73 (5 ULiège)
Full Text
See detailInfluence of drospirenone on renin-angiotensin-aldosterone system evaluation
VROONEN, Laurent ULiege; Cavalier, Etienne ULiege; Vranken, Laura ULiege et al

in Endocrine Abstracts - 13th European Congress of Endocrinology (2011)

Detailed reference viewed: 45 (6 ULiège)
Full Text
Peer Reviewed
See detailHigh prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
Tichomirowa, Maria A; Barlier, Anne; Daly, Adrian ULiege et al

in European Journal of Endocrinology (2011), 165(4), 509-15

BACKGROUND: Aryl hydrocarbon receptor interacting protein (AIP) mutations (AIPmut) cause aggressive pituitary adenomas in young patients, usually in the setting of familial isolated pituitary adenomas ... [more ▼]

BACKGROUND: Aryl hydrocarbon receptor interacting protein (AIP) mutations (AIPmut) cause aggressive pituitary adenomas in young patients, usually in the setting of familial isolated pituitary adenomas. The prevalence of AIPmut among sporadic pituitary adenoma patients appears to be low; studies have not addressed prevalence in the most clinically relevant population. Hence, we undertook an international, multicenter, prospective genetic, and clinical analysis at 21 tertiary referral endocrine departments. METHODS: We included 163 sporadic pituitary macroadenoma patients irrespective of clinical phenotype diagnosed at <30 years of age. RESULTS: Overall, 19/163 (11.7%) patients had germline AIPmut; a further nine patients had sequence changes of uncertain significance or polymorphisms. AIPmut were identified in 8/39 (20.5%) pediatric patients. Ten AIPmut were identified in 11/83 (13.3%) sporadic somatotropinoma patients, in 7/61 (11.5%) prolactinoma patients, and in 1/16 non-functioning pituitary adenoma patients. Large genetic deletions were not seen using multiplex ligation-dependent probe amplification. Familial screening was possible in the relatives of seven patients with AIPmut and carriers were found in six of the seven families. In total, pituitary adenomas were diagnosed in 2/21 AIPmut-screened carriers; both had asymptomatic microadenomas. CONCLUSION: Germline AIPmut occur in 11.7% of patients <30 years with sporadic pituitary macroadenomas and in 20.5% of pediatric patients. AIPmut mutation testing in this population should be considered in order to optimize clinical genetic investigation and management. [less ▲]

Detailed reference viewed: 54 (12 ULiège)
Full Text
Peer Reviewed
See detailUne nouvelle forme d'adénomes hypophysaires familiaux : les FIPA-Détection et prise en charge
Beckers, Albert ULiege; PETROSSIANS, Patrick ULiege; Auriemma, R. S. et al

in Correspondances en MHDN (2011)

Detailed reference viewed: 53 (11 ULiège)